Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Consumer healthcare giant Johnson & Johnson is expected to kick off a review for its estimated $2.5 billion-plus global media business in the first half of next year, according to sources.
The competition will follow the company’s $16.6 billion acquisition of Pfizer Consumer Health Care, which is expected to close in late December.
J&J spends about $1.3 billion on ads in the U.S. alone, according to Nielsen Monitor-Plus.
The company is not expected to issue a proposal request until after the first of the year, sources said.
Current
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in